<i>The Journal of Clinical Hypertension</i> Has Become the Official Journal of the World Hypertension League

For many years The Journal of Clinical Hypertension (JCH) has been a major resource for research, clinical practice, and healthcare policy in the broad realm of hypertension. JCH has been fortunate that so many leaders in these domains have contributed reports of original studies, scholarly review articles, and critical commentaries to the pages of the Journal. Clearly this support has been the basis for making JCH such an influential force in hypertension. Thanks to its new partnership with the World Hypertension League (WHL), the editors of the Journal—together with its publisher, Wiley—are poised to take the next major step in embracing the full spectrum of clinical hypertension and making JCH the preeminent journal in the field. The WHL is a remarkable entity. One of its major roles is to serve as the umbrella organization for national societies of hypertension—currently 42 of them—including such major ones as the American Society of Hypertension, the Chinese Hypertension League, the International Society of Hypertension in Blacks, the Hypertension Society of India, and the Russian Society of Hypertension. As well, the WHL partners with organizations such as The National Forum for Heart Disease and Stroke Prevention in the implementation of prevention and disease management strategies. This allows WHL to have a truly global reach in defining public health and policy agendas and in providing education and guidance in the practice of hypertension and other areas of preventive medicine. In support of these large-scale international commitments, the WHL has established formal relationships with both the World Health Organization in Geneva and the International Society of Hypertension. Readers not familiar with the full scope of the WHL's activities can visit their Web site (www.worldhypertensionleague.org) for further information. As a practical expression of our new relationship, JCH will soon be publishing official WHL position papers and fact sheets designed to define policy and provide support for clinicians and other public health leaders on such issues as dietary salt, definitions of hypertension, and the use of semi-automated blood pressure devices. Beyond that, we expect to publish original research articles and reviews that encompass a broad range of related topics. Needless to say, JCH intends to continue its commitment to all aspects of clinical hypertension. We strongly invite authors to submit their work in related areas including, but not limited to: drug trials or other therapeutic interventions; studies of patient compliance with treatment and ways to improve it; population studies and epidemiology of hypertension; predictors of hypertension; associations with concomitant conditions; pharmacoeconomics and other cost issues; diagnostic features of hypertension, including studies of arterial stiffness, central blood pressure, and other vascular measurements; relationships between blood biomarkers and hypertension; basic science and molecular biology studies that help define the clinical characteristics of hypertension; research on the effects of hypertension on target organs, particularly coronary disease and left ventricular dysfunction, stroke and other central nervous system events, chronic kidney disease, and peripheral artery disease; and treatment-resistant hypertension. In short, we put no limits on interesting work that contributes to our understanding and management of hypertension! In January of this year, JCH published a major hypertension guideline paper titled, “Clinical Practice Guidelines for the Management of Hypertension in the Community: A Statement by the American Society of Hypertension and the International Society of Hypertension.”1 This work was targeted at practitioners throughout the world and was written in such a way as to be applicable to hypertension care regardless of local economic or social conditions. While this effort has already been very enthusiastically received, it will soon be necessary to begin the work of updating and expanding the guideline so that it can continue to be a major resource for practitioners on the front lines of managing hypertension. The exciting new relationship between the WHL and JCH will provide a powerful impetus for this critical endeavor.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.